Stock ARRD RESE
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar ARRD RESE Nasdaq

Equities

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for ARRD RESE
07-05 HC Wainwright Cuts Price Target on Arrowhead Pharmaceuticals to $60 From $90, Keeps Buy Rating MT
06-25 Arrowhead Pharmaceuticals to Advance Investigational Medicine Plozasiran Into Late-stage Cardiovascular Study MT

Chart calendar ARRD RESE

580335.ZdpHtOLMzjnbiRDtYFgoFNtIN7IIPmkYebyb6W41dic.NKsv0bP1v1-eunalBDRAfagNRf1faTxKMuj9kSMDHBMq6CTH0LSITrTwew~7f92bc5b2f19916d7d72138f1aa4c4f3

Upcoming events on ARRD RESE

04/08/2024 Q3 2024 Earnings Release (Projected)
14/08/2024 R&D Webinar - Obesity / Metabolic
24/09/2024 R&D Webinar - Central Nervous System
24/11/2024 Q4 2024 Earnings Release (Projected)
04/02/2025 Q1 2025 Earnings Release (Projected)
07/05/2025 Q2 2025 Earnings Release (Projected)

Past events on ARRD RESE

Today R&D Webinar - Pulmonary
28/06/2024 18:00 RNA Therapeutics Conference
25/06/2024 19:00 R&D Webinar
23/06/2024 American Diabetes Association Scientific Symposium
12/06/2024 Nephrology of Asian Pacific Congress
12/06/2024 21:00 Goldman Sachs Global Healthcare Conference
06/06/2024 European Association for the Study of the Liver Congress - Proteomic Analysis
06/06/2024 European Association for the Study of the Liver Congress - Intrahepatic
05/06/2024 17:30 Jefferies Global Healthcare Conference
02/06/2024 06:00 European Glaucoma Society Congress
01/06/2024 20:20 National Lipid Association Scientific Conference
31/05/2024 22:30 National Lipid Association Scientific Conference
29/05/2024 10:30 European Atherosclerosis Society Congress
28/05/2024 13:49 European Atherosclerosis Society Congress
28/05/2024 11:04 European Atherosclerosis Society Congress
23/05/2024 19:00 R&D Webinar - Part I
22/05/2024 01:45 International Conference on Antiviral Research
20/05/2024 19:30 American Thoracic Society Conference - Lung-targeted RNAi
20/05/2024 19:30 American Thoracic Society Conference - M1 mRNAs
19/05/2024 19:30 American Thoracic Society Conference - ARO-RAGE

Annual results

Fiscal PeriodSeptember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		169
167
1.13%		88,0
135
-34.65%		138
142
-2.76%		243
294
-17.16%		241
264
-8.67%
107

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-87,2
-40,4
-115.82%		-141
-89,9
-56.6%		-168
-87,9
-91.14%		-193
-159
-21.17%
-368

EBIT
Million USD		Released
Forecast
Spread 		61,2
67,0
-8.7%		-93,2
-59,8
-55.68%		-149
-114
-30.83%		-179
-135
-32.5%		-205
-162
-26.6%
-393

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		61,2
73,0
-16.23%		-84,6
-42,3
-99.8%		-141
-108
-29.92%		-173
-149
-16.06%		-206
-159
-29.54%
-393

Net income
Million USD		Released
Forecast
Spread 		68,0
73,0
-6.94%		-84,6
-42,3
-99.81%		-141
-108
-29.92%		-176
-149
-18.32%		-205
-151
-36.13%
-360

EPS
USD		Released
Forecast
Spread 		0,69
0,73
-6.03%		-0,84
-0,45
-85.64%		-1,36
-1,05
-30.06%		-1,67
-1,46
-14.41%		-1,92
-1,51
-26.73%
-3,14

Announcement Date25/11/1923/11/2022/11/2128/11/2229/11/23-

Quarterly results

Fiscal PeriodSeptember 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3
Net sales
Million USD		Released
Forecast
Spread 		152
131
15.79%		32,4
52,6
-38.39%		31,6
91,2
-65.38%		62,5
163
-61.51%		146
45,5
221.61%		15,8
45,4
-65.16%		16,1
47,0
-65.73%		3,55
29,6
-88.02%		0,00
56,8
-
37,1


38,9


21,7


22,5


29,2

EBITDA
Million USD		Released
Forecast
Spread 		44,1
-20,3
317.83%		-70,3
-74,5
5.67%		-81,2
-27,2
-198.42%		-39,4
148
-126.69%		50,8
-106
148%		-99,4
-133
25.41%		-104
-93,1
-12.21%		-132
-101
-31.23%
-86,9


-0,80


-28,6










EBIT
Million USD		Released
Forecast
Spread 		41,6
47,4
-12.26%		-72,9
-67,6
-7.89%		-83,8
-53,8
-55.96%		-42,1
65,4
-164.46%		48,2
-74,6
164.55%		-103
-67,5
-52.12%		-108
-67,2
-61.28%		-137
-98,0
-39.38%		-126
-42,3
-198.14%
-76,2


-76,5


-114


-114


-109

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		44,4
17,8
149.15%		-72,0
-62,7
-14.88%		-82,2
-58,3
-41%		-41,8
82,7
-150.54%		47,7
-75,7
162.99%		-103
-63,7
-62.22%		-109
-60,4
-80.54%		-139
-101
-37.1%		-127
-38,4
-230.34%
-80,1


-60,9


-101


-97,1


-106

Net income
Million USD		Released
Forecast
Spread 		44,4
43,9
1.1%		-72,0
-41,1
-75.24%		-85,5
-58,3
-46.76%		-41,8
72,3
-157.83%		47,7
-65,2
173.12%		-103
-56,1
-83.67%		-110
-52,2
-110.22%		-133
-88,1
-50.76%		-125
-15,6
-705.53%
-72,0


-48,7


-101


-97,1


-106

EPS
USD		Released
Forecast
Spread 		0,41
0,29
40.47%		-0,68
-0,47
-43.93%		-0,81
-0,52
-56.22%		-0,39
0,67
-158.51%		0,45
-0,61
173.96%		-0,96
-0,59
-63.5%		-1,02
-0,58
-75.41%		-1,24
-0,81
-54.01%		-1,02
-0,22
-369.12%
-0,57


-0,47


-0,84


-0,84


-0,81

Announcement Date10/05/2204/08/2228/11/2206/02/2302/05/2307/08/2329/11/2306/02/2409/05/24-----

Upcoming sector events for ARRD RESE

23/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 06:00 ARGENX SE: Q2 2024 Earnings Release
29/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 EXELIXIS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for ARRD RESE

11/07/2024 21:00 NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release
08/07/2024 LUMOSA THERAPEUTICS CO., LTD.: June 2024 Sales and Revenue Release
07/07/2024 TAIMED BIOLOGICS INC.: June 2024 Sales and Revenue Release
04/07/2024 PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release
06/06/2024 LUMOSA THERAPEUTICS CO., LTD.: May 2024 Sales and Revenue Release
06/06/2024 TAIMED BIOLOGICS INC.: May 2024 Sales and Revenue Release
05/06/2024 08:51 PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 12:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 12:46 BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 06:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. ARWR Stock
  4. Stock
  5. Calendar ARRD RESE